Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.
about
Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal RuleParticulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogensCharacterization of the Burkholderia mallei tonB Mutant and Its Potential as a Backbone Strain for Vaccine DevelopmentThe Autotransporter BpaB Contributes to the Virulence of Burkholderia mallei in an Aerosol Model of InfectionRecombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.Characterization of an autotransporter adhesin protein shared by Burkholderia mallei and Burkholderia pseudomallei.Identification of Burkholderia mallei and Burkholderia pseudomallei adhesins for human respiratory epithelial cells.Immunospecific responses to bacterial elongation factor Tu during Burkholderia infection and immunization.Production and characterization of chimeric monoclonal antibodies against Burkholderia pseudomallei and B. mallei using the DHFR expression system.Protective antigens against glanders identified by expression library immunization.Immunogenic Consensus Sequence T helper Epitopes for a Pan-Burkholderia Biodefense Vaccine.Burkholderia thailandensis oacA mutants facilitate the expression of Burkholderia mallei-like O polysaccharides.Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in miceIn Vitro and In Vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei.Low-dose exposure of C57BL/6 mice to burkholderia pseudomallei mimics chronic human melioidosisA naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glandersBurkholderia vaccines: are we moving forward?Burkholderia mallei CLH001 Attenuated Vaccine Strain Is Immunogenic and Protects against Acute Respiratory Glanders.Monitoring Therapeutic Treatments against Burkholderia Infections Using Imaging TechniquesRevised structures for the predominant O-polysaccharides expressed by Burkholderia pseudomallei and Burkholderia mallei.Comparative Burkholderia pseudomallei natural history virulence studies using an aerosol murine model of infection.Genetic and biochemical map for the biosynthesis of occidiofungin, an antifungal produced by Burkholderia contaminans strain MS14.Deciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens.Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.Melioidosis and glanders modulation of the innate immune system: barriers to current and future vaccine approaches.Recent Advances in Burkholderia mallei and B. pseudomallei Research.Rapid DNA vaccination against Burkholderia pseudomallei flagellin by tattoo or intranasal application.Cloning, purification, crystallization and preliminary X-ray analysis of the Burkholderia pseudomallei L1 ribosomal protein.Vaccines for the Prevention of Melioidosis and Glanders.
P2860
Q26859041-1642396B-E0FF-4F07-9C18-CCFC652A1399Q27011190-28FFBDEA-D059-49D5-901F-E17E9DA2D9B9Q27304432-ACA24FEA-67BA-4A65-82A7-98292B723D6AQ27307715-623C2982-84F4-429F-B48D-C11CEA7E40F1Q30279061-11D8880B-4006-4F50-AE9D-1C1C11A8B51AQ33611911-F6EF16F3-507C-46CA-8D4D-6AD73EC3F5A7Q33709714-B4298388-8A0A-4551-B755-CBCC69261621Q33778331-A31EB39A-B179-4DDF-8CAC-1F9DEBF8A30FQ33900390-F14B7B8D-2A71-4B1E-A61C-C6F9DE330CCBQ34085654-B704DAC5-0E59-435B-A34E-1157A5F0A612Q34388865-A089B264-30D4-4B57-A85F-4AA24B0CCFA1Q34529504-FFF9F665-26FB-40EE-9960-171E54F40D8FQ35009671-B74F120C-21E6-4C71-B773-81EC183BF96BQ35066127-5C140D88-A24A-4FF5-B017-150654BCDFA3Q35070115-528130B0-E846-47D7-802A-0D0B9C95F4E8Q35375333-EABC94CE-744A-4859-B6C8-2E6598E2AB9EQ36164961-D16C7C0E-A123-4176-8EA3-459D937BBDA7Q36587103-D112978A-EBCA-40C5-9110-DF073DF77D47Q37129909-616318B1-1D8D-4593-8E72-5043AD63DF98Q37384332-891328DE-F3FA-428E-B987-57715B91A833Q37582243-9E9B88E6-806C-4A6D-BDE1-F9933C34B1C5Q37623675-568779B7-D5D2-4B0D-8701-CD1DEDDC1ABFQ38283421-3EAC96D2-6C0F-40D6-8D48-0AF648801F97Q38287677-F8A12667-1A73-4359-937D-261DAA7445B5Q38784773-340E7E67-0BE7-429A-A5D7-096471BBBC04Q38890754-AD69DC91-9721-4D6E-9AD0-55E4FE07868FQ39970602-0100CD0E-0D12-42AE-B863-7409AD00D60EQ40286028-46B3C314-2496-4270-98AF-BE41D25C9278Q42000081-D30DFAD9-168D-4259-B0BB-A44DB34C8357Q49834322-B6BAA4ED-31D5-4E27-9171-09A46923FE0E
P2860
Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei
@nl
Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.
@ast
Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.
@en
type
label
Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei
@nl
Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.
@ast
Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.
@en
prefLabel
Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei
@nl
Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.
@ast
Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.
@en
P2860
P921
P1476
Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.
@en
P2093
Joanna B Goldberg
Sara K Bondi
P2860
P304
P356
10.1586/14760584.7.9.1357
P407
P577
2008-11-01T00:00:00Z